As one of around 2,800 exhibitors, Hastamat will be presenting their innovative packaging solutions at this year's interpack in Düsseldorf. From 7 to 13 May, the German machine manufacturer will be ...
A global biopharmaceutical company has announced it will invest $1. 5 billion for a new manufacturing facility in Bradley, ...
CSL Seqirus has entered into a pioneering long-term agreement with the Pan American Health Organization (PAHO) Regional ...
CSL is one of three Tier 1 plasma therapy companies that benefit from an oligopoly in a highly consolidated market. All the players are vertically integrated as plasma sourcing is a key constraint in ...
SYDNEY--Australia-based pharmaceutical company CSL will expand its Illinois manufacturing facility under a previously announced $1.5 billion move to increase U.S. production. CSL, which produces ...
Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...
Australia-headquartered CSL Limted broke ground Monday for the $1.5 billion expansion of its manufacturing facility in Kankakee, Illinois, USA.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
CSL has FDA approval for its new drug to prevent hereditary angioedema (HAE) attacks, Andembry, offering a new, first-in-class option for patients with the rare genetic disorder. Factor XIIa inhibitor ...
BMW has introduced the 2027 M4 Coupe M Legacy Edition, a limited run of models to celebrate 40 years since the M3 Coupe first debuted. Of course, the M3 name was eventually dropped for the M4 on the ...
Going into the 21st century, BMW was riding a tidal wave of success. The core 3, 5, and 7 Series sedans were at the peak of their powers, the original X5 redefined how well an SUV could drive, and BMW ...
Final stats and insights from a reporting season in February that decisively broke with the negative trend in earnings growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results